PlainRecalls
FDA Drug Moderate Class II Terminated

Geodon for injection (ziprasidone mesylate), 20 mg/mL, 1 mL single dose vial, Rx only, MFG: Viatris, NDC 0049-3920-83

Reported: June 15, 2022 Initiated: April 13, 2022 #D-1112-2022

Product Description

Geodon for injection (ziprasidone mesylate), 20 mg/mL, 1 mL single dose vial, Rx only, MFG: Viatris, NDC 0049-3920-83

Reason for Recall

cGMP deviations: Temperature abuse

Details

Units Affected
1 carton/10 vials
Distribution
USA nationwide.
Location
Richmond, VA

Frequently Asked Questions

What product was recalled?
Geodon for injection (ziprasidone mesylate), 20 mg/mL, 1 mL single dose vial, Rx only, MFG: Viatris, NDC 0049-3920-83. Recalled by Mckesson Medical-Surgical Inc. Corporate Office. Units affected: 1 carton/10 vials.
Why was this product recalled?
cGMP deviations: Temperature abuse
Which agency issued this recall?
This recall was issued by the FDA Drug on June 15, 2022. Severity: Moderate. Recall number: D-1112-2022.